| Dr Nathan David Joos, MD | |
|
2000 S 900 E, Salt Lake City, UT 84105-3208 | |
| (801) 464-7510 | |
| Not Available |
| Full Name | Dr Nathan David Joos |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 18 Years |
| Location | 2000 S 900 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417096090 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | 13019723-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park City Hospital | Park city, UT | Hospital |
| Lds Hospital | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Experts believe that plain packaging of tobacco products would cut smoking, a new study has found. Tobacco control experts from around the world estimate that two years after the introduction of generic packaging the number of adult smokers would be reduced by one percentage point (in the UK - from 21 to 20%), and the percentage of children trying smoking would be reduced by three percentage points (in the UK - from 27 to 24%).
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Treatment that consisted of shock wave (procedure using high-dose ultrasound)-mediated preconditioning of the target heart tissue prior to administration of bone marrow-derived mononuclear cells was associated with significant, albeit modest improvement in left ventricular ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction) after 4 months in patients with chronic postinfarction heart failure, according to a study in the April 17 issue of JAMA.
The Global Coalition against Child Pneumonia recently announced the World Pneumonia Day 2011 Small Grants Program, aimed at funding innovative events and activities on or around World Pneumonia Day that address gaps in prevention and control of the disease, according to a press release.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Experts believe that plain packaging of tobacco products would cut smoking, a new study has found. Tobacco control experts from around the world estimate that two years after the introduction of generic packaging the number of adult smokers would be reduced by one percentage point (in the UK - from 21 to 20%), and the percentage of children trying smoking would be reduced by three percentage points (in the UK - from 27 to 24%).
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Treatment that consisted of shock wave (procedure using high-dose ultrasound)-mediated preconditioning of the target heart tissue prior to administration of bone marrow-derived mononuclear cells was associated with significant, albeit modest improvement in left ventricular ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction) after 4 months in patients with chronic postinfarction heart failure, according to a study in the April 17 issue of JAMA.
The Global Coalition against Child Pneumonia recently announced the World Pneumonia Day 2011 Small Grants Program, aimed at funding innovative events and activities on or around World Pneumonia Day that address gaps in prevention and control of the disease, according to a press release.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathan David Joos, MD 2000 S 900 E, Salt Lake City, UT 84105-3208 Ph: (801) 464-7510 | Dr Nathan David Joos, MD 2000 S 900 E, Salt Lake City, UT 84105-3208 Ph: (801) 464-7510 |
News Archive
Experts believe that plain packaging of tobacco products would cut smoking, a new study has found. Tobacco control experts from around the world estimate that two years after the introduction of generic packaging the number of adult smokers would be reduced by one percentage point (in the UK - from 21 to 20%), and the percentage of children trying smoking would be reduced by three percentage points (in the UK - from 27 to 24%).
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Treatment that consisted of shock wave (procedure using high-dose ultrasound)-mediated preconditioning of the target heart tissue prior to administration of bone marrow-derived mononuclear cells was associated with significant, albeit modest improvement in left ventricular ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction) after 4 months in patients with chronic postinfarction heart failure, according to a study in the April 17 issue of JAMA.
The Global Coalition against Child Pneumonia recently announced the World Pneumonia Day 2011 Small Grants Program, aimed at funding innovative events and activities on or around World Pneumonia Day that address gaps in prevention and control of the disease, according to a press release.
› Verified 6 days ago
Dr. Kendall M. Burgett, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-662-5663 | |
Dr. Jason P Hunt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Russell Jon Ord, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 333 S 900 E, Salt Lake City, UT 84102 Phone: 801-535-8185 Fax: 801-355-4011 | |
Dr. David Parker Hill, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2000 S 900 E, Salt Lake City, UT 84105 Phone: 801-464-7660 Fax: 801-464-7558 | |
Dr. Bethany R Powers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6322 S 3000 E Ste 170, Salt Lake City, UT 84121 Phone: 801-513-3223 | |
Christopher A. Hamilton, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 North Medical Dr Som 3c120, Salt Lake City, UT 84132 Phone: 801-581-7514 | |
Quinn Taylor Orb, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Som 3c-120, Salt Lake City, UT 84132 Phone: 801-581-7514 Fax: 801-585-5744 |